Cue Biopharma, Inc.
NASDAQ:CUE
0.565 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -50.733 | -53.01 | -44.161 | -44.785 | -36.699 | -38.98 | -23.234 | -7.658 | -1.929 |
| Depreciation & Amortization
| 3.436 | 1.806 | -1.778 | 1.057 | 5.166 | 0.76 | 0.42 | 0.202 | 0.045 |
| Deferred Income Tax
| -15.923 | 0 | 0 | 0.084 | -0.018 | 0.08 | 0.011 | 0 | 0 |
| Stock Based Compensation
| 8.18 | 9.496 | 11.516 | 10.481 | 6.521 | 7.174 | 2.775 | 0.89 | 0 |
| Change In Working Capital
| -0.934 | 0.356 | -4.387 | 1.232 | -1.489 | 4.211 | 2.909 | 0.532 | 0.147 |
| Accounts Receivables
| -1.641 | 3.085 | -1.725 | -0.663 | -0.755 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 4.79 | 4.853 | -0.51 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0.77 | 0.083 | 0.52 | 0.741 | -1.153 | 0.376 | 0.562 | 0 | 0.178 |
| Other Working Capital
| -0.063 | -2.812 | -7.973 | -3.699 | 0.929 | 3.835 | 2.347 | 0.532 | -0.031 |
| Other Non Cash Items
| 16.013 | -0.454 | -0.026 | -0.563 | -4.278 | 0.345 | 4.928 | 0.066 | 0.08 |
| Operating Cash Flow
| -39.961 | -41.806 | -38.837 | -32.494 | -30.797 | -26.411 | -12.192 | -5.968 | -1.658 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| 0 | -0.171 | -0.913 | -0.595 | -0.046 | -1.854 | -1.205 | -0.516 | -0.754 |
| Acquisitions Net
| 0.002 | 0.006 | 0.005 | 0.084 | 0.128 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | -29.445 | -0.005 | -9.949 | -15.134 | -39.5 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 25 | 5 | 10 | 15 | 18.5 | 21 | 0 | 0 | 0 |
| Other Investing Activites
| 25.002 | -24.439 | 0.022 | -0.084 | 3.493 | -18.5 | -0 | -0 | -0.05 |
| Investing Cash Flow
| 25.002 | -24.61 | 9.109 | 4.456 | 3.447 | -20.354 | -1.205 | -0.516 | -0.804 |
| Financing Activities: | |||||||||
| Debt Repayment
| -2 | -10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 13.86 | 44.001 | 17.385 | 56.682 | 48.999 | 4.169 | 66.155 | 16.415 | 10.004 |
| Common Stock Repurchased
| 0 | -0.2 | -0.75 | -0.271 | -0.091 | 0 | -4.16 | -1.41 | -1.138 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 13.86 | 43.859 | 2.599 | 2.203 | 1.882 | 0.013 | 0.009 | -1.41 | 0.001 |
| Financing Cash Flow
| 11.86 | 53.659 | 19.233 | 58.614 | 50.79 | 4.182 | 62.004 | 15.005 | 8.867 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -3.1 | -12.757 | -10.495 | 30.576 | 23.44 | -42.583 | 48.608 | 8.521 | 6.405 |
| Cash At End Of Period
| 48.514 | 51.764 | 64.521 | 75.016 | 44.44 | 21 | 63.534 | 14.926 | 6.405 |